These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 282007)

  • 1. Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortus.
    Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
    Cancer Treat Rep; 1978 Nov; 62(11):1931-5. PubMed ID: 282007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel.
    Schultz RM; Chirigos MA; Pavlidis NA; Youngner JS
    Cancer Treat Rep; 1978 Nov; 62(11):1937-41. PubMed ID: 103619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.
    Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
    Infect Immun; 1979 Jan; 23(1):19-26. PubMed ID: 106004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the activity of a Brucella abortus preparation, Bru-Pel.
    Youngner JS; Feingold DS; Keleti G
    Cancer Treat Rep; 1978 Nov; 62(11):1915-8. PubMed ID: 728911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B; Gebhardt M
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity.
    Youdim
    Cancer Res; 1977 Apr; 37(4):991-6. PubMed ID: 403003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymhocyte stimulatory effect of an ether-extracted preparation of Brucella abortus.
    Stylos WA; Chirigos MA; Lengel CR
    Cancer Treat Rep; 1978 Nov; 62(11):1949-54. PubMed ID: 310345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage involvement in the antitumor activity of Brucella abortus ether extract against experimental lung carcinoma metastases.
    Schultz RM; Pavlidis NA; Chirigos MA
    Cancer Res; 1978 Oct; 38(10):3427-31. PubMed ID: 99230
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture.
    Bartholeyns J; Lombard Y; Poindron P
    Anticancer Res; 1988; 8(1):145-51. PubMed ID: 3358630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased mortality of Norman murine sarcoma in mice treated with the immunomodulator, Acemannan.
    Peng SY; Norman J; Curtin G; Corrier D; McDaniel HR; Busbee D
    Mol Biother; 1991 Jun; 3(2):79-87. PubMed ID: 1910624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of non-specific cytotoxic cells in Listeria-susceptible and -resistant mouse strains.
    Wood P; Cheers C
    Immunology; 1985 Jan; 54(1):113-9. PubMed ID: 3918933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vitro cytolytic effect of hepatic, splenic and peritoneal macrophages from glucan-treated mice on sarcoma M5076.
    Sherwood ER; Williams DL; Di Luzio NR
    Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):157-61. PubMed ID: 3713379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages and Brucella.
    Baldwin CL; Winter AJ
    Immunol Ser; 1994; 60():363-80. PubMed ID: 8251581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of natural killer cell activity in mice by Bru-Pel.
    Yabu K; Youngner JS; Feingold DS; Keleti G; Gorelik E
    J Immunother (1991); 1991 Oct; 10(5):307-12. PubMed ID: 1790138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide modulation of the immune response in female B6C3F1 mice: a host resistance study.
    Karrow NA; Guo TL; Zhang LX; McCay JA; Musgrove DL; Peachee VL; Germolec DR; White KL
    Int Immunopharmacol; 2003 Oct; 3(10-11):1447-56. PubMed ID: 12946441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice.
    Cheers C; Waller R
    J Immunol; 1975 Sep; 115(3):844-7. PubMed ID: 807647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host resistance to the LVS strain of Francisella tularensis in BCG vaccinated mice.
    Taplits MS; Myrvik QN
    J Reticuloendothel Soc; 1977 Oct; 22(4):297-308. PubMed ID: 411926
    [No Abstract]   [Full Text] [Related]  

  • 19. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
    Ogura T; Hara H; Yokota S; Hosoe S; Kawase I; Kishimoto S; Yamamura Y
    Cancer Res; 1985 Dec; 45(12 Pt 1):6371-5. PubMed ID: 4063987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots.
    Suzuki F; Schmitt DA; Utsunomiya T; Pollard RB
    In Vivo; 1992; 6(6):589-96. PubMed ID: 1296807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.